Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapy
Not Applicable
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000006519
- Lead Sponsor
- Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Contraindication for risedronate use 2. medicated with Warfarin 3. Using other osteoporosis drugs (active vitamin D3,SERM, ipriflavone, calcitonin, bisphosphonate) 4. Patients judged inappropriate by attending physisians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of bone mineral density and serum markers for bone turnover
- Secondary Outcome Measures
Name Time Method